Skip to main content
SpringerLink
Log in

Antifungals: Mechanism of Action and Drug Resistance

  • Chapter
  • First Online:
Yeast Membrane Transport

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 892))

Abstract

There are currently few antifungals in use which show efficacy against fungal diseases. These antifungals mostly target specific components of fungal plasma membrane or its biosynthetic pathways. However, more recent class of antifungals in use is echinocandins which target the fungal cell wall components. The availability of mostly fungistatic antifungals in clinical use, often led to the development of tolerance to these very drugs by the pathogenic fungal species. Thus, the development of clinical multidrug resistance (MDR) leads to higher tolerance to drugs and its emergence is helped by multiple mechanisms. MDR is indeed a multifactorial phenomenon wherein a resistant organism possesses several mechanisms which contribute to display reduced susceptibility to not only single drug in use but also show collateral resistance to several drugs. Considering the limited availability of antifungals in use and the emergence of MDR in fungal infections, there is a continuous need for the development of novel broad spectrum antifungal drugs with better efficacy. Here, we briefly present an overview of the current understanding of the antifungal drugs in use, their mechanism of action and the emerging possible novel antifungal drugs with great promise.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Balashov SV, Park S, Perlin DS (2006) Assessing resistance to the echinocandin antifungal drug caspofungin in Candida albicans by profiling mutations in FKS1. Antimicrob Agents Chemother 50:2058–2063

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bills GF, Platas G, Overy DP, Collado J, Fillola A, Jiménez MR et al (2009) Discovery of the parnafungins, antifungal metabolites that inhibit mRNA polyadenylation, from the Fusarium larvarum complex and other Hypocrealean fungi. Mycologia 101:449–472

    Article  CAS  PubMed  Google Scholar 

  • Bink A, Pellens K, Cammue BPA, Thevissen K (2011) Anti-Biofilm Strategies: how to Eradicate Candida Biofilms? Open Mycol J 5:29–38

    Article  CAS  Google Scholar 

  • Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC (2012) Hidden killers: human fungal infections. Sci Transl Med 4:165rv13

    Google Scholar 

  • Calabrese EC, Castellano S, Santoriello M, Sgherri C, Quartacci MF, Calucci L et al (2013) Antifungal activity of azole compounds CPA18 and CPA109 against azole-susceptible and -resistant strains of Candida albicans. J Antimicrob Chemother 68:1111–1119

    Article  CAS  PubMed  Google Scholar 

  • Cannon RD, Lamping E, Holmes AR, Niimi K, Baret PV, Keniya MV et al (2009) Efflux-mediated antifungal drug resistance. Clin Microbiol Rev 22:291–321

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Capobianco JO, Zakula D, Coen ML, Goldman RC (1993) Anti-Candida activity of cispentacin: the active transport by amino acid permeases and possible mechanisms of action. Biochem Biophys Res Commun 190:1037–1044

    Article  CAS  PubMed  Google Scholar 

  • De Backer MD, Ilyina T, Ma XJ, Vandoninck S, Luyten WH, Vanden Bossche H (2001) Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray. Antimicrob Agents Chemother 45:1660–1670

    Article  PubMed  PubMed Central  Google Scholar 

  • Dean M, Andrey R, Rando A (2001) The human ATP-binding cassette (ABC) transporter superfamily. Genome Res 11:1156–1166

    Article  CAS  PubMed  Google Scholar 

  • Decottignies A, Grant AM, Nichols JW, De Wet H, McIntosh DB, Goffeau A (1998) ATPase and multidrug transport activities of the overexpressed yeast ABC protein Yor1p. J Biol Chem 273:12612–12622

    Article  CAS  PubMed  Google Scholar 

  • Dhamgaye S, Devaux F, Manoharlal R, Vandeputte P, Shah AH, Singh A et al (2012) In vitro effect of malachite green on Candida albicans involves multiple pathways and transcriptional regulators UPC2 and STP2. Antimicrob Agents Chemother 56:495–506

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dhamgaye S, Devaux F, Vandeputte P, Khandelwal NK, Sanglard D, Mukhopadhyay G et al (2014) Molecular mechanisms of action of herbal antifungal alkaloid berberine, in Candida albicans. PLoS One 9:e104554

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Domínguez JM, Martín JJ (1998) Identification of elongation factor 2 as the essential protein targeted by sordarins in Candida albicans. Antimicrob Agents Chemother 42:2279–2283

    PubMed  PubMed Central  Google Scholar 

  • Domínguez JM, Kelly VA, Kinsman OS, Marriott MS, Gómez de las Heras F, Martín JJ (1998) Sordarins: a new class of antifungals with selective inhibition of the protein synthesis elongation cycle in yeasts. Antimicrob Agents Chemother 42:2274–2278

    PubMed  PubMed Central  Google Scholar 

  • Espinel-Ingroff A (2009) Novel antifungal agents, targets or therapeutic strategies for the treatment of invasive fungal diseases: a review of the literature (2005–2009). Rev Iberoam Micol 26:15–22

    Article  PubMed  Google Scholar 

  • Espinel-Ingroff A, Canton E, Martin-Mazuelos E, Pemán J (2009) Pharmacotherapy of Candida Infections with Echinocandins. Clin Med Ther 1:889–897

    CAS  Google Scholar 

  • Flowers SA, Barker KS, Berkow EL, Toner G, Chadwick SG, Gygax SE et al (2012) Gain-of function mutations in UPC2 are a frequent cause of ERG11 upregulation in azole-resistant clinical isolates of Candida albicans. Eukaryot Cell 11:1289–1299

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fostel JM, Lartey PA (2000) Emerging novel antifungal agents. Drug Discov Today 5:25–32

    Google Scholar 

  • Gallo-Ebert C, Donigan M, Stroke IL, Swanson RN, Manners MT, Francisco J et al (2014) Novel antifungal drug discovery based on targeting pathways regulating the fungus-conserved Upc2 transcription factor. Antimicrob Agents Chemother 58:258–266

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Garbati MA, Alasmari FA, Al-Tannir MA, Tleyjeh IM (2012) The role of combination antifungal therapy in the treatment of invasive aspergillosis: a systematic review. Int J Infect Dis 16:e76–e81

    Article  CAS  PubMed  Google Scholar 

  • Garcia-Effron G, Park S, Perlin DS (2009) Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints. Antimicrob Agents Chemother 53:112–122

    Article  CAS  PubMed  Google Scholar 

  • Gaur M, Choudhury D, Prasad R (2005) Complete inventory of ABC proteins in human pathogenic yeast, Candida albicans. J Mol Microbiol Biotechnol 9:3–15

    Article  CAS  PubMed  Google Scholar 

  • Gaur M, Puri N, Manoharlal R, Rai V, Mukhopadhayay G, Choudhury D et al (2008) MFS transportome of the human pathogenic yeast Candida albicans. BMC Genomics 9:579

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Ghannoum MA, Spellberg BJ, Ibrahim AS, Ritchie JA, Currie B, Spitzer ED et al (1994) Sterol composition of Cryptococcus neoformans in the presence and absence of fluconazole. Antimicrob Agents Chemother 38:2029–2033

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Golin J, Ambudkar SV, May L (2007) The yeast Pdr5p multidrug transporter: how does it recognize so many substrates? Biochem Biophys Res Commun 356:1–5

    Article  CAS  PubMed  Google Scholar 

  • Gow NA, Hube B (2012) Importance of the Candida albicans cell wall during commensalism and infection. Curr Opin Microbiol 15:406–412

    Article  CAS  PubMed  Google Scholar 

  • Gubbins PO, Anaissie E (2006) Overview of antifungal agents. Pharmacy practice news special edition 59–64

    Google Scholar 

  • Gunawardana G, Rasmussen RR, Scherr M, Frost D, Brandt KD, Choi W et al (1997) Corynecandin: a novel antifungal glycolipid from Coryneum modonium. J Antibiot (Tokyo) 50:884–886

    Article  CAS  Google Scholar 

  • Harris GH, Shafiee A, Cabello MA, Curotto JE, Genilloud O, Göklen KE et al (1998) Inhibition of fungal sphingolipid biosynthesis by rustmicin, galbonolide B and their new 21-hydroxy analogs. J Antibiot (Tokyo) 51:837–844

    Article  CAS  Google Scholar 

  • Heilmann CJ, Schneider S, Barker KS, Rogers PD, Morschhäuser J (2010) An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicans. Antimicrob Agents Chemother 54:353–359

    Article  CAS  PubMed  Google Scholar 

  • Heitman J (2011) Microbial pathogens in the fungal kingdom. Fungal Biol Rev 25:48–60

    Article  PubMed  PubMed Central  Google Scholar 

  • Henry KW, Nickels JT, Edlind TD (2000) Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors. Antimicrob Agents Chemother 44:2693–2700

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Herreros E, Martinez CM, Almela MJ, Marriott MS, De Las Heras FG, Gargallo-Viola D (1998) Sordarins: in vitro activities of new antifungal derivatives against pathogenic yeasts, Pneumocystis carinii, and filamentous fungi. Antimicrob Agents Chemother 42:2863–2869

    CAS  PubMed  PubMed Central  Google Scholar 

  • Hodgetts S, Nooney L, Al-Akeel R, Curry A, Awad S, Matthews R et al (2008) Efungumab and caspofungin: pre-clinical data supporting synergy. J Antimicrob Chemother 61:1132–1139

    Article  CAS  PubMed  Google Scholar 

  • Hoot SJ, Smith AR, Brown RP, White TC (2011) An A643V amino acid substitution in Upc2p contributes to azole resistance in well-characterized clinical isolates of Candida albicans. Antimicrob Agents Chemother 55:940–942

    Article  CAS  PubMed  Google Scholar 

  • Iwamoto T, Tsujii E, Ezaki M, Fujie A, Hashimoto S, Okuhara M et al (1990) FR109615, a new antifungal antibiotic from Streptomyces setonii. Taxonomy, fermentation, isolation, physico-chemical properties and biological activity. J Antibiot (Tokyo) 43:1–7

    Article  CAS  Google Scholar 

  • Jiang B, Xu D, Allocco J, Parish C, Davison J, Veillette K et al (2008) PAP inhibitor with in vivo efficacy identified by Candida albicans genetic profiling of natural products. Chem Biol 15:363–374

    Article  CAS  PubMed  Google Scholar 

  • Jiménez-Ortigosa C, Paderu P, Motyl MR, Perlin DS (2014) Enfumafungin derivative MK-3118 shows increased in vitro potency against clinical echinocandin-resistant Candida Species and Aspergillus species isolates. Antimicrob Agents Chemother 58:1248–1251

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Kakeya H, Miyazaki Y, Senda H, Kobayashi T, Seki M, Izumikawa K et al (2008a) Efficacy of SPK-843, a novel polyene antifungal, in comparison with amphotericin B, liposomal amphotericin B, and micafungin against murine pulmonary aspergillosis. Antimicrob Agents Chemother 52:1868–1870

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kakeya H, Miyazaki Y, Senda H, Kobayashi T, Seki M, Izumikawa K et al (2008b) Efficacy of SPK-843, a novel polyene antifungal, in a murine model of systemic cryptococcosis. Antimicrob Agents Chemother 52:1871–1872

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kaneto R, Chiba H, Agematu H, Shibamoto N, Yoshioka T, Nishida H et al (1993) Mer-WF3010, a new member of the papulacandin family. I. Fermentation, isolation and characterization. J Antibiot (Tokyo) 46:247–250

    Article  CAS  Google Scholar 

  • Kantarcioglu AS, Yucel A, Vidotto V (2003) In vitro activity of a new polyene SPK-843 against Candida spp, Cryptococcus neoformans and Aspergillus spp. clinical isolates. J Chemother 15:296–298

    Article  CAS  PubMed  Google Scholar 

  • Karababa M, Coste AT, Rognon B, Bille J, Sanglard D (2004) Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters. Antimicrob Agents Chemother 48:3064–3079

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Katiyar SK, Edlind TD (2001) Identification and expression of multidrug resistance related ABC transporter genes in Candida krusei. Med Mycol 39:109–116

    Article  CAS  PubMed  Google Scholar 

  • Kinsman OS, Chalk PA, Jackson HC, Middleton RF, Shuttleworth A, Rudd BA et al (1998) Isolation and characterisation of an antifungal antibiotic (GR135402) with protein synthesis inhibition. J Antibiot (Tokyo) 51:41–49

    Article  CAS  Google Scholar 

  • Kitamura A, Someya K, Hata M, Nakajima R, Takemura M (2009) Discovery of a small-molecule inhibitor of {beta}-1,6-glucan synthesis. Antimicrob Agents Chemother 53:670–677

    Article  CAS  PubMed  Google Scholar 

  • Kohli A, Smirti, Mukhopadhyay K, Rattan A, Prasad R (2002) In vitro low-level resistance to azole in Candida albicans is associated with changes in membrane fluidity and asymmetry. Antimicrob Agents Chemother 46:1046–1052

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Konishi M, Nishio M, Saitoh K, Miyaki T, Oki T, Kawaguchi H (1989) Cispentacin, a new antifungal antibiotic. I. Production, isolation, physico-chemical properties and structure. J Antibiot (Tokyo) 42:1749–1755

    Article  CAS  Google Scholar 

  • Kusch H, Biswas K, Schwanfelder S, Engelmann S, Rogers PD, Hecker M et al (2004) A proteomic approach to understanding the development of multidrug-resistant Candida albicans strains. Mol Genet Genomics 271:554–565

    Article  CAS  PubMed  Google Scholar 

  • Lamb DC, Maspahy S, Kelly DE, Manning NJ, Geber A, Bennett JE et al (1999) Purification, reconstitution, and inhibition of cytochrome P-450 sterol delta22-desaturase from the pathogenic fungus Candida glabrata. Antimicrob Agents Chemother 43:1725–1728

    CAS  PubMed  PubMed Central  Google Scholar 

  • Lamping E, Baret PV, Holmes AR, Monk BC, Goffeau A, Cannon RD (2010) Fungal PDR transporters: phylogeny, topology, motifs and function. Fungal Genet Biol 47:127–142

    Article  CAS  PubMed  Google Scholar 

  • Lemke A, Kiderlen AF, Kayser O (2005) Amphotericin B. Appl Microbiol Biotechnol 68:151–162

    Article  CAS  PubMed  Google Scholar 

  • Lewis RE, Kontoyiannis DP (2001) Rationale for combination antifungal therapy. Pharmacotherapy 21:149S–164S

    Article  CAS  PubMed  Google Scholar 

  • Liu TT, Lee REB, Barker KS, Lee RE, Wei L, Homayouni R et al (2005) Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. Antimicrob Agents Chemother 49:2226–2236

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • López-Martínez R (2010) Candidosis, a new challenge. Clin Dermatol 28:178–184

    Article  PubMed  Google Scholar 

  • Mandala SM, Thornton RA, Rosenbach M, Milligan J, Garcia-Calvo M, Bull HG et al (1997) Khafrefungin, a novel inhibitor of sphingolipid synthesis. J Biol Chem 272:32709–32714

    Article  CAS  PubMed  Google Scholar 

  • Mandala SM, Thornton RA, Milligan J, Rosenbach M, Garcia-Calvo M, Bull HG et al (1998) Rustmicin, a potent antifungal agent, inhibits sphingolipid synthesis at inositol phosphoceramide synthase. J Biol Chem 273:14942–14949

    Article  CAS  PubMed  Google Scholar 

  • Mansfield BE, Oltean HN, Oliver BG, Hoot SJ, Leyde SE, Hedstrom L et al (2010) Azole drugs are imported by facilitated diffusion in Candida albicans and other pathogenic fungi. PLoS Pathog 6(9):e1001126

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Marichal P, Koymans L, Willemsens S, Bellens D, Verhasselt P, Luyten W et al (1999) Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. Microbiology 145:2701–2713

    Article  CAS  PubMed  Google Scholar 

  • Martel CM, Parker JE, Bader O, Weig M, Gross U, Warrilow AG et al (2010) A clinical isolate of Candida albicans with mutations in ERG11 (encoding sterol 14alpha-demethylase) and ERG5 (encoding C22 desaturase) is cross resistant to azoles and amphotericin B. Antimicrob Agents Chemother 54:3578–3583

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Miceli MH, Bernardo SM, Lee SA (2009) In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms. Int J Antimicrob Agents 34:326–332

    Article  CAS  PubMed  Google Scholar 

  • Mitsuyama J, Nomura N, Hashimoto K, Yamada E, Nishikawa H, Kaeriyama M et al (2008) In vitro and in vivo antifungal activities of T-2307, a novel arylamidine. Antimicrob Agents Chemother 52:1318–1324

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Miyazaki H, Miyazaki Y, Geber A, Parkinson T, Hitchcock C et al (1998) Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata. Antimicrob Agents Chemother 42:1695–1701

    CAS  PubMed  PubMed Central  Google Scholar 

  • Moran GP, Sanglard D, Donnelly SM, Shanley DB, Sullivan DJ, Coleman DC (1998) Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis. Antimicrob Agents Chemother 42:1819–1830

    CAS  PubMed  PubMed Central  Google Scholar 

  • Morio F, Loge C, Besse B, Hennequin C, Le Pape P (2010) Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature. Diagn Microbiol Infect Dis 66:373–384

    Article  CAS  PubMed  Google Scholar 

  • Munro CA, Winter K, Buchan A, Henry K, Becker JM, Brown AJ et al (2001) Chs1 of Candida albicans is an essential chitin synthase required for synthesis of the septum and for cell integrity. Mol Microbiol 39:1414–1426

    Article  CAS  PubMed  Google Scholar 

  • Nagiec MM, Nagiec EE, Baltisberger JA, Wells GB, Lester RL, Dickson RC (1997) Sphingolipid synthesis as a target for antifungal drugs. Complementation of the inositol phosphorylceramide synthase defect in a mutant strain of Saccharomyces cerevisiae by the AUR1 gene. J Biol Chem 272:9809–9817

    Article  CAS  PubMed  Google Scholar 

  • Nishi I, Sunada A, Toyokawa M, Asari S, Iwatani Y (2009) In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species. J Infect Chemother 15:1–5

    Article  CAS  PubMed  Google Scholar 

  • Ogawa A, Hashida-Okado T, Endo M, Yoshioka H, Tsuruo T, Takesako K et al (1998) Role of ABC transporters in aureobasidin A resistance. Antimicrob Agents Chemother 42:755–761

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Okada H, Kamiya S, Shiina Y, Suwa H, Nagashima M, Nakajima S et al (1998) BE-31405, a new antifungal antibiotic produced by Penicillium minioluteum. I. Description of producing organism, fermentation, isolation, physico-chemical and biological properties. J Antibiot (Tokyo) 51:1081–1086

    Article  CAS  Google Scholar 

  • Olson JA, Adler-Moore JP, Smith PJ, Proffitt RT (2005) Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin. Antimicrob Agents Chemother 49:4895–4902

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pagant S, Halliday JJ, Kougentakis C, Miller EA (2010) Intragenic suppressing mutations correct the folding and intracellular traffic of misfolded mutants of Yor1p, a eukaryotic drug transporter. J Biol Chem 285:36304–36314

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pai MP, Samples ML, Mercier RC, Spilde MN (2008) Activities and ultrastructural effects of antifungal combinations against simulated Candida endocardial vegetations. Antimicrob Agents Chemother 52:2367–2376

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Parish CA, Smith SK, Calati K, Zink D, Wilson K, Roemer T et al (2008) Isolation and structure elucidation of parnafungins, antifungal natural products that inhibit mRNA polyadenylation. J Am Chem Soc 130:7060–7066

    Article  CAS  PubMed  Google Scholar 

  • Park S, Kelly R, Kahn JN, Robles J, Hsu MJ, Register E et al (2005) Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates. Antimicrob Agents Chemother 49:3264–3273

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pasrija R, Banerjee D, Prasad R (2007) Structure and function analysis of CaMdr1p, a major facilitator superfamily antifungal efflux transporter protein of Candida albicans: identification of amino acid residues critical for drug/H+ transport. Eukaryot Cell 6:443–453

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Perlin DS (2007) Resistance to echinocandin-class antifungal drugs. Drug Resist Updat 10:121–130

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Perlin DS (2011) Current perspectives on echinocandin class drugs. Future Microbiol 6:441–457

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Petraitis V, Petraitiene R, Kelaher AM, Sarafandi AA, Sein T, Mickiene D et al (2004) Efficacy of PLD-118, a novel inhibitor of candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant C. albicans. Antimicrob Agents Chemother 48:3959–3967

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Prasad R, Goffeau A (2012) Yeast ATP-binding cassette transporters conferring multidrug resistance. Annu Rev Microbiol 66:39–63

    Article  CAS  PubMed  Google Scholar 

  • Prasad R, Kapoor K (2005) Multidrug resistance in yeast Candida. Int Rev Cytol 242:215–248

    Article  CAS  PubMed  Google Scholar 

  • Prasad R, DeWergifosse P, Goffeau A, Balzi E (1995) Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr Genet 27:320–329

    Article  CAS  PubMed  Google Scholar 

  • Prasad T, Hameed S, Manoharlal R, Biswas S, Mukhopadhyay CK, Goswami SK et al (2010) Morphogenic regulator EFG1 affects the drug susceptibilities of pathogenic Candida albicans. FEMS Yeast Res 10:587–596

    CAS  PubMed  Google Scholar 

  • Rodrigues ME, Silva S, Azeredo J, Henriques M (2014) Novel strategies to fight Candida species infection. Crit Rev Microbiol 10:1–13

    Article  CAS  Google Scholar 

  • Roemer T, Krysan DJ (2014) Antifungal drug development: challenges, unmet clinical needs, and new approaches. Cold Spring Harb Perspect Med 4 pii:a019703

    Google Scholar 

  • Saier MH Jr, Beatty JT, Goffeau A, Harley KT, Heijne WHM, Huang SC et al (1999) The major facilitator superfamily. J Mol Microbiol Biotechnol 1:257–279

    CAS  PubMed  Google Scholar 

  • Sanglard D, Ischer F, Calabrese D, Majcherczyk PA, Bille J (1999) The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. Antimicrob Agents Chemother 43:2753–2765

    CAS  PubMed  PubMed Central  Google Scholar 

  • Sanglard D, Ischer F, Parkinson T, Falconer D, Bille J (2003) Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents. Antimicrob Agents Chemother 47:2404–2412

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sanglard D, Coste A, Ferrari S (2009) Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation. FEMS Yeast Res 9:1029–1050

    Article  CAS  PubMed  Google Scholar 

  • Sanguinetti M, Posteraro B, La Sorda M, Torelli R, Fiori B, Santangelo R et al (2006) Role of AFR1, an ABC transporter-encoding gene, in the in vivo response to fluconazole and virulence of Cryptococcus neoformans. Infect Immun 74:1352–1359

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sasse C, Schillig R, Reimund A, Merk J, Morschhäuser J (2012) Inducible and constitutive activation of two polymorphic promoter alleles of the Candida albicans multidrug efflux pump MDR1. Antimicrob Agents Chemother 56:4490–4494

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Serena C, Fernández-Torres B, Pastor FJ, Trilles L, Lazéra Mdos S, Nolard N et al (2005) In vitro interactions of micafungin with other antifungal drugs against clinical isolates of four species of Cryptococcus. Antimicrob Agents Chemother 49:2994–2996

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shapiro RS, Robbins N, Cowen LE (2011) Regulatory circuitry governing fungal development, drug resistance, and disease. Microbiol Mol Biol Rev 75:213–267

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sharma M, Manoharlal R, Shukla S, Puri N, Prasad T, Ambudkar SV et al (2009) Curcumin modulates efflux mediated by yeast ABC multidrug transporters and is synergistic with antifungals. Antimicrob Agents Chemother 53:3256–3265

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sharma M, Manoharlal R, Puri N, Prasad R (2010) Antifungal curcumin induces reactive oxygen species and triggers an early apoptosis but prevents hyphae development by targeting the global repressor TUP1 in Candida albicans. Biosci Rep 30:391–404

    Article  CAS  PubMed  Google Scholar 

  • Shi W, Chen Z, Chen X, Cao L, Liu P, Sun S (2010) The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents. FEMS Yeast Res 10:885–893

    Article  CAS  PubMed  Google Scholar 

  • Shibata T, Takahashi T, Yamada E, Kimura A, Nishikawa H, Hayakawa H et al (2012) T-2307 causes collapse of mitochondrial membrane potential in yeast. Antimicrob Agents Chemother 56:5892–5897

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • St Georgiev V (2000) Membrane transporters and antifungal drug resistance. Curr Drug Targets 1:261–284

    Article  CAS  PubMed  Google Scholar 

  • Stephanie SP, Paulsen IT, Saier MH Jr (1998) Major facilitator superfamily. Microbiol Mol Biol Rev 62:1–34

    Google Scholar 

  • Thornewell SJ, Peery RB, Skatrud PL (1997) Cloning and characterization of CneMDR1: a Cryptococcus neoformans gene encoding a protein related to multidrug resistance proteins. Gene 201:21–29

    Article  CAS  PubMed  Google Scholar 

  • Tobudic S, Kratzer C, Lassnigg A, Graninger W, Presterl E (2010a) In vitro activity of antifungal combinations against Candida albicans biofilms. J Antimicrob Chemother 65:271–274

    Article  CAS  PubMed  Google Scholar 

  • Tobudic S, Lassnigg A, Kratzer C, Graninger W, Presterl E (2010b) Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases. Mycoses 53:208–214

    Article  CAS  PubMed  Google Scholar 

  • Torelli R, Posteraro B, Ferrari S, La Sorda M, Fadda G, Sanglard D et al (2008) The ATP-binding cassette transporter-encoding gene CgSNQ2 is contributing to the CgPDR1-dependent azole resistance of Candida glabrata. Mol Microbiol 68:186–201

    Article  CAS  PubMed  Google Scholar 

  • Uppuluri P, Nett J, Heitman J, Andes D (2008) Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms. Antimicrob Agents Chemother 52:1127–1132

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vanden Bossche H, Marichal P, Le Jeune L, Coene MC, Gorrens J, Cools W (1993) Effects of itraconazole on cytochrome P-450-dependent sterol 14 alpha-demethylation and reduction of 3-ketosteroids in Cryptococcus neoformans. Antimicrob Agents Chemother 37:2101–2105

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vandeputte P, Tronchin G, Berge`s T, Hennequin C, Chabasse D, Bouchara JP (2007) Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth. Antimicrob Agents Chemother 51:982–990

    Article  CAS  PubMed  Google Scholar 

  • Vandeputte P, Ferrari S, Coste AT (2012) Antifungal resistance and new strategies to control fungal infections. Int J Microbiol 2012:713687

    Article  PubMed  CAS  Google Scholar 

  • Verrier PJ, Bird D, Burla B, Dassa E, Forestier C, Geisler M et al (2008) Plant ABC proteins—a unified nomenclature and updated inventory. Trends Plant Sci 13:151–159

    Article  CAS  PubMed  Google Scholar 

  • Wang H, Kong F, Sorrell TC, Wang B, McNicholas P, Pantarat N et al (2009) Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing. BMC Microbiol 14:167

    Article  CAS  Google Scholar 

  • White TC, Silver PM (2005) Regulation of sterol metabolism in Candida albicans by the UPC2 gene. Biochem Soc Trans 33:1215–1218

    Article  CAS  PubMed  Google Scholar 

  • White TC, Marr KA, Bowden RA (1998) Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 11:382–402

    CAS  PubMed  PubMed Central  Google Scholar 

  • White TC, Holleman S, Dy F, Mirels LF, Stevens DA (2002) Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob Agents Chemother 46:1704–1713

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wiederhold NP, Najvar LK, Fothergill AW, Bocanegra R, Olivo M, McCarthy DI et al (2015) The Novel Arylamidine T-2307 Maintains In Vitro and In Vivo Activity against Echinocandin-Resistant Candida albicans. Antimicrob Agents Chemother 59:1341–1343

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Young LY, Hull CM, Heitman J (2003) Disruption of ergosterol biosynthesis confers resistance to amphotericin B in Candida lusitaniae. Antimicrob Agents Chemother 47:2717–2724

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang YQ, Gamarra S, Garcia-Effron G, Park S, Perlin DS, Rao R (2010) Requirement for ergosterol in V-ATPase function underlies antifungal activity of azole drugs. PLoS Pathog 6:e1000939

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Membrane Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, 110067, India

    Rajendra Prasad, Abdul Haseeb Shah & Manpreet Kaur Rawal

  2. AMITY Institute of Integrative Sciences and Health (AIISH), Amity University Haryana, Manesar, Gurgaon, Haryana, India

    Rajendra Prasad

Authors
  1. Rajendra Prasad
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abdul Haseeb Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Manpreet Kaur Rawal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rajendra Prasad .

Editor information

Editors and Affiliations

  1. Dept. of Microbiology, University of Córdoba, Córdoba, Spain

    José Ramos

  2. Department of Membrane Transport, Institute of Physiology, The Czech Academy of Sciences, Prague, Czech Republic

    Hana Sychrová

  3. Department of Mathematics and Technology, University of Applied Sciences, Koblenz, Remagen, Germany

    Maik Kschischo

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Prasad, R., Shah, A.H., Rawal, M.K. (2016). Antifungals: Mechanism of Action and Drug Resistance. In: Ramos, J., Sychrová, H., Kschischo, M. (eds) Yeast Membrane Transport. Advances in Experimental Medicine and Biology, vol 892. Springer, Cham. https://doi.org/10.1007/978-3-319-25304-6_14

Download citation

Publish with us

Policies and ethics

Search

Navigation